Regulating the new reproductive technologies: a cross-channel comparison.
D026683:Advisory Committees; D000367:Age Factors; D003219:Confidentiality; D030881:Disclosure; D019924:Embryo Disposition; D033041:Embryo Research; D004622:Embryo, Mammalian; D005307:Fertilization in Vitro; D005380:Financing, Government; D005602:France; D033161:Government Regulation; D015276:Health Care Rationing; D006716:Homosexuality; D006801:Humans; D007206:Individuality; D007258:Informed Consent; D007315:Insemination, Artificial; D007391:International Cooperation; D038622:Internationality; D007603:Jurisprudence; D007878:Legislation as Topic; D009313:National Health Programs; D018587:Oocyte Donation; D010287:Parent-Child Relations; D018579:Patient Selection; D028723:Personhood; D037022:Posthumous Conception; D011640:Public Policy; D012098:Reproduction; D027724:Reproductive Techniques, Assisted; D012106:Research; D012847:Single Person; D012926:Social Control, Formal; D013094:Spermatozoa; D014019:Tissue Donors; D006113:United Kingdom
Centre d'Etude et de Conservation du Sperme Humain (CECOS); Genetics and Reproduction; Human Fertilisation and Embryology Act 1990 (Great Britain); Human Fertilisation and Embryology Authority; Legal Approach; National Health Service; Parpalaix v. CECOS; R v. Human Fertilisation and Embryology Authority (ex parte Blood)